» Articles » PMID: 29228551

Human Cytomegalovirus and Herpes Simplex Type I Virus Can Engage RNA Polymerase I for Transcription of Immediate Early Genes

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Dec 13
PMID 29228551
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Human cytomegalovirus (HCMV) utilizes RNA polymerase II to transcribe viral genes and produce viral mRNAs. It can specifically target the nucleolus to facilitate viral transcription and translation. As RNA polymerase I (Pol I)-mediated transcription is active in the nucleolus, we investigated the role of Pol I, along with relative contributions of the human Pol II and Pol III, to early phases of viral transcription in HCMV infected cells, compared with Herpes Simplex Virus-1 (HSV-1) and Murine cytomegalovirus (MCMV). Inhibition of Pol I with siRNA or the Pol I inhibitors CX-5461 or Actinomycin D (5nM) resulted in significantly decreased IE and pp65 mRNA and protein levels in human fibroblasts at early times post infection. This initially delayed replication was compensated for later during the replication process, at which stage it didn't significantly affect virus production. Pol I inhibition also reduced HSV-1 ICP0 and gB transcripts, suggesting that some herpesviruses engage Pol I for their early transcription. In contrast, inhibition of Pol I failed to affect MCMV transcription. Collectively, our results contribute to better understanding of the functional interplay between RNA Pol I-mediated nucleolar events and the Herpes viruses, particularly HCMV whose pathogenic impact ranges from congenital malformations and potentially deadly infections among immunosuppressed patients, up to HCMV's emerging oncomodulatory role in human tumors.

Citing Articles

CMV-induced Hearing Loss.

Singh S, Maheshwari A, Boppana S Newborn (Clarksville). 2024; 2(4):249-262.

PMID: 38348106 PMC: 10860330. DOI: 10.5005/jp-journals-11002-0081.


Pluripotential GluN1 (NMDA NR1): Functional Significance in Cellular Nuclei in Pain/Nociception.

McNearney T, Westlund K Int J Mol Sci. 2023; 24(17).

PMID: 37686003 PMC: 10488196. DOI: 10.3390/ijms241713196.


Insight for Immunotherapy of HCMV Infection.

Long X, Qiu Y, Zhang Z, Wu M Int J Biol Sci. 2021; 17(11):2899-2911.

PMID: 34345215 PMC: 8326118. DOI: 10.7150/ijbs.58127.


A Review of the Potential Role of Human Cytomegalovirus (HCMV) Infections in Breast Cancer Carcinogenesis and Abnormal Immunity.

Geisler J, Touma J, Rahbar A, Soderberg-Naucler C, Vetvik K Cancers (Basel). 2019; 11(12).

PMID: 31766600 PMC: 6966479. DOI: 10.3390/cancers11121842.

References
1.
Rubbi C, Milner J . Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 2003; 22(22):6068-77. PMC: 275437. DOI: 10.1093/emboj/cdg579. View

2.
Pestov D, Strezoska Z, Lau L . Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol Cell Biol. 2001; 21(13):4246-55. PMC: 87085. DOI: 10.1128/MCB.21.13.4246-4255.2001. View

3.
Hannan K, Hannan R, Rothblum L . Transcription by RNA polymerase I. Front Biosci. 1998; 3:d376-98. DOI: 10.2741/a282. View

4.
Lu M, Shenk T . Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. J Virol. 1996; 70(12):8850-7. PMC: 190981. DOI: 10.1128/JVI.70.12.8850-8857.1996. View

5.
Harkins L, Volk A, Samanta M, Mikolaenko I, Britt W, Bland K . Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet. 2002; 360(9345):1557-63. DOI: 10.1016/S0140-6736(02)11524-8. View